A28 Therapeutics
A28 Therapeutics is a startup headquartered in La Jolla, United States, founded in 2021. It has raised at least $1.9m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
A28 Therapeutics has raised at least $1.9m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
A28 Therapeutics sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in La Jolla
- AeroRx Therapeutics
- Arialys Therapeutics
- DEPTH Health
- Enlaza Therapeutics
- Paulex Bio
- RightDevice
- Sylke
- Valora Therapeutics
Related
- Innovation profile of La Jolla
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does A28 Therapeutics do?
A28 Therapeutics is classed in technology in its filings with the US Securities and Exchange Commission.
How much has A28 Therapeutics raised?
At least $1.9m, according to its Form D filings with the US Securities and Exchange Commission.
Where is A28 Therapeutics based?
A28 Therapeutics is headquartered in La Jolla, United States.
When was A28 Therapeutics founded?
A28 Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.